Workflow
人福医药: 人福医药2025年第四次临时股东会会议资料

Meeting Details - The meeting is scheduled for September 12, 2025, at 14:00 [1] - The location is at the conference room of Renfu Pharmaceutical Group in Wuhan [1] - Voting will be conducted both on-site and through the Shanghai Stock Exchange online voting system [1] Agenda - The meeting will start with the announcement of attendance and reading of the meeting guidelines [2] - Shareholders will review two main proposals: 1. Reappointment of Da Xin Accounting Firm as the auditor for the fiscal year 2025 [5] 2. Signing a financial services agreement with China Merchants Group Finance Co., Ltd. [10] Proposal 1: Reappointment of Da Xin Accounting Firm - The company proposes to reappoint Da Xin Accounting Firm for the 2025 financial year, with the audit fee not exceeding the 2024 fee of 5.2 million yuan [5][9] - Da Xin Accounting Firm has over 30 years of experience in securities services and has a network of 39 member firms globally [6] - The firm had a total revenue of 1.378 billion yuan in 2024, with 405 million yuan from securities services [6] Proposal 2: Financial Services Agreement with China Merchants Group Finance Co., Ltd. - The agreement aims to enhance the company's financing channels and reduce financing costs, with a maximum daily deposit balance of 200 million yuan and a maximum loan balance of 500 million yuan [10][11] - The agreement is classified as a related party transaction due to the ownership structure of China Merchants Group Finance Co., Ltd. [11] - The financial services agreement is set for a duration of three years [13]